The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase Ib study of pembrolizumab following trans-arterial chemoembolization (TACE) in hepatocellular carcinoma (HCC): PETAL.
 
Claudia A.M. Fulgenzi
No Relationships to Disclose
 
Alessio Cortellini
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; MSD Oncology; Roche
Speakers' Bureau - AstraZeneca; Eisai
 
Antonio D'Alessio
No Relationships to Disclose
 
Robert Thomas
No Relationships to Disclose
 
Paul Tait
Consulting or Advisory Role - Sirtex medical; Sirtex medical
Travel, Accommodations, Expenses - Sirtex medical
 
Paul J. Ross
No Relationships to Disclose
 
Anna-Mary Young
No Relationships to Disclose
 
Thomas Talbot
No Relationships to Disclose
 
Robert Goldin
No Relationships to Disclose
 
Caroline Ward
No Relationships to Disclose
 
Bertram Bengsch
Employment - iOMEDICO (I)
Patents, Royalties, Other Intellectual Property - Wo2019084495A1
 
Rohini Sharma
No Relationships to Disclose
 
David J. James Pinato
Honoraria - Avammune; Bristol-Myers Squibb; Da Volterra; Mursla Bio; Roche/Genentech
Consulting or Advisory Role - AstraZeneca; Da Volterra; Eisai; H3 Biomedicine; Ipsen; Mina Therapeutics; Roche
Speakers' Bureau - Bayer; Falk Pharma; Roche; ViiV Healthcare
Research Funding - Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); MSD Oncology (Inst)
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; MSD Oncology
Other Relationship - Wiley